Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpromazine + Promethazine Neuroprotection in Acute Ischemic Stroke
ChiCTR2000038727Phase 4Not yet recruiting
- Sponsor
- Beijing Luhe Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Aminazin and promethazine in ischemic stroke (2 arms), sponsored by Beijing Luhe Hospital. Primary endpoint: 90-day modified Rankin Scale (mRS) score. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
Aminazinpromethazine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000038727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038727.